9.00
price up icon6.92%   0.61
 
loading
Schlusskurs vom Vortag:
$8.39
Offen:
$8.92
24-Stunden-Volumen:
781.72K
Relative Volume:
2.79
Marktkapitalisierung:
$188.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-43.33
EPS:
-0.2077
Netto-Cashflow:
$-44.93M
1W Leistung:
+14.42%
1M Leistung:
+12.70%
6M Leistung:
+1.71%
1J Leistung:
-10.92%
1-Tages-Spanne:
Value
$8.75
$9.83
1-Wochen-Bereich:
Value
$7.88
$9.83
52-Wochen-Spanne:
Value
$4.81
$13.88

Cybin Inc Stock (CYBN) Company Profile

Name
Firmenname
Cybin Inc
Name
Telefon
908 764 8385
Name
Adresse
100 King Street West, Suite 5600, Toronto
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CYBN's Discussions on Twitter

Vergleichen Sie CYBN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CYBN
Cybin Inc
9.0199 188.40M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.75 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.09 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.57 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.67 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.00 28.51B 3.81B -644.79M -669.77M -6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Guggenheim Buy
2021-11-19 Herabstufung Maxim Group Buy → Hold

Cybin Inc Aktie (CYBN) Neueste Nachrichten

pulisher
Jun 18, 2025

Cybin CEO Doug Drysdale: Revolutionizing Depression Treatment - worth.com

Jun 18, 2025
pulisher
Jun 18, 2025

Psychedelic Industry Summit: Top CEOs and Investors Unite to Shape $Billion Market Future - Stock Titan

Jun 18, 2025
pulisher
Jun 13, 2025

Cybin Provides Corporate Update and Highlights Positive Regulato - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

# Cybin begins phase 3 trials for depression treatment CYB003 By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Silicon Valley - FinancialContent

Jun 13, 2025
pulisher
Jun 13, 2025

Cybin Advances Phase 3 Program Amid Positive Regulatory Signals - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

# Cybin begins phase 3 trials for depression treatment CYB003 - Investing.com Australia

Jun 13, 2025
pulisher
Jun 13, 2025

Cybin Provides Corporate Update, Highlights Positive Regulatory Signals For Psychedelic Therapeutics - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Should You Buy Polkadot While It's Under $5? - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire

Jun 13, 2025
pulisher
Jun 13, 2025

Prediction: This Company Will Be the Most Valuable AI Stock in 2026 - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

Billionaire Bill Ackman Just Scooped Up Shares of This Unstoppable Stock - The Globe and Mail

Jun 13, 2025
pulisher
Jun 12, 2025

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Per - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference | CYBN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

Cybin to Participate in the 2025 Psychedelic Science Conference - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cybin to Participate in the 2025 Psychedelic Science Conference | CYBN Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 10, 2025

Crypto's hottest new trend: publicly traded companies buying bunches of bitcoin - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

(CYBN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 09, 2025

Cybin, Inc: The Strategic Approach to Formulating a Successful CYB003 Launch - Smartkarma

Jun 09, 2025
pulisher
Jun 06, 2025

Cybin (CYBN) Gains Positive Outlook from Lucid Capital | CYBN St - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Market Analysis: June 6th, 2025 - The Globe and Mail

Jun 06, 2025
pulisher
Jun 06, 2025

lucid capital markets initiates buy rating on cybin stock - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

lucid capital markets initiates buy rating on cybin stock By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Cybin (CYBN) Gains Positive Outlook from Lucid Capital | CYBN Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 05, 2025

Cybin secures U.S. patent for program targeting generalized Anxiety disorder and depression - Proactive Investors

Jun 05, 2025
pulisher
Jun 05, 2025

Cybin, Inc.The Strategic Approach to Formulating a Successful CYB003 Launch - Smartkarma

Jun 05, 2025
pulisher
Jun 05, 2025

Massive News for DraftKings Stock Investors - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Psychedelic Drugs Market 2025 | Growth Trends, Mental Health - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - BioSpace

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin secures patent for anxiety disorder treatment CYB004 - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin Granted Additional US Patent for Potential Anxiety Disorder Treatments - MarketScreener

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin secures patent for anxiety disorder treatment CYB004 By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin (CYBN) Secures U.S. Patent for CYB004 Program | CYBN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cybin Announces Additional U.S. Patent Supporting its CYB004 Pro - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Will Blue Chip UPS Deliver for Shareholders? - The Globe and Mail

Jun 03, 2025
pulisher
May 30, 2025

Cybin taps Thermo Fisher for U.S. manufacturing of CYB003 - MSN

May 30, 2025
pulisher
May 29, 2025

Transcript : Cybin Inc.Special Call - marketscreener.com

May 29, 2025
pulisher
May 28, 2025

(CYBN) Proactive Strategies - news.stocktradersdaily.com

May 28, 2025
pulisher
May 25, 2025

Prediction: Dogecoin Will Plummet to New Lows by the End of the Year. Here's Why. - The Globe and Mail

May 25, 2025
pulisher
May 24, 2025

Cboe Canada Single Security - Cboe Global Markets

May 24, 2025
pulisher
May 24, 2025

Billionaire CEO Jamie Dimon Just Delivered a Stark Warning to the Market. Here Are 3 Things Investors Should Do. - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

This Chinese Robotaxi Stock Could Be an Even Better Buy Than Tesla Before June - The Globe and Mail

May 23, 2025
pulisher
May 22, 2025

Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat - TipRanks

May 22, 2025
pulisher
May 22, 2025

Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 - BioSpace

May 22, 2025
pulisher
May 22, 2025

Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 | CYBN Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Cybin CEO Reveals Latest on Phase 3 Psychedelics Program and FDA Developments in Exclusive Analyst Chat - Stock Titan

May 22, 2025

Finanzdaten der Cybin Inc-Aktie (CYBN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):